Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (116)

« Back to Publications

Single intramuscular injection of self-amplifying RNA of Nppa to treat myocardial infarction.

Zhang K. et al, (2026), Science, 391

Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy.

Anderson S. et al, (2026), Nat Cardiovasc Res, 5, 138 - 154

First-in-Human Study of the Carbohydrate Nanoparticle 64Cu-Macrin.

O'Shea A. et al, (2025), J Nucl Med

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.

Hundertmark MJ. et al, (2025), Circulation

Safety and Feasibility of Magnetic Resonance Imaging Within the First Week Following Transvenous Pacing System Implantation.

Raby J. et al, (2025), Circulation, 152, 1393 - 1395

Non-Invasive Wearable Technology to Predict Heart Failure Decompensation.

Devin J. et al, (2025), J Clin Med, 14

Cardiac energetics in severe mitral regurgitation: relationship with eccentric hypertrophy, stroke volume, and effects of valve repair.

Peterzan MA. et al, (2025), Eur Heart J Imaging Methods Pract, 3

B cells promote atrial fibrillation via autoantibodies.

Yamazoe M. et al, (2025), Nat Cardiovasc Res, 4, 1381 - 1396

Regression of late gadolinium enhancement in a case of eosinophilic granulomatous polyangiitis with cardiac involvement.

Tang P-T. et al, (2025), Eur Heart J Cardiovasc Imaging, 26

Resistin-like molecule γ attacks cardiomyocyte membranes and promotes ventricular tachycardia.

Kumowski N. et al, (2025), Science, 389, 1043 - 1048

Obesity and heart failure: exploring the cardiometabolic axis.

Rayner JJ. et al, (2025), Cardiovasc Res, 121, 1173 - 1186

Metabolic flexibility and reverse remodelling of the failing human heart.

Green PG. et al, (2025), Eur Heart J, 46, 2422 - 2433

Sex-specific cardiometabolic multimorbidity, metabolic syndrome and left ventricular function in heart failure with preserved ejection fraction in the UK Biobank.

Bertrand A. et al, (2025), Cardiovasc Diabetol, 24

MicroRNA-210 Enhances Cell Survival and Paracrine Potential for Cardiac Cell Therapy While Targeting Mitophagy.

Alonaizan R. et al, (2025), J Funct Biomater, 16

Immunomodulation by AZD1656 reverses cardiac dysfunction, metabolic remodelling and reduces infarct size in type 2 diabetic cardiomyopathy.

Anderson S. et al, (2025)

Load More

1
2
3
4
5
6
7
...
»